-
1
-
-
1542348477
-
Cancer statistics, 2004
-
Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 8-29
-
-
Jemal, A.1
Tiwari, R.C.2
Murray, T.3
Ghafoor, A.4
Samuels, A.5
Ward, E.6
-
2
-
-
0037811742
-
Barriers to clinical trial participation by older women with breast cancer
-
Kemeny M.M., Peterson B.L., Kornblith A.B., Muss H.B., Wheeler J., Levine E., et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21 (2003) 2268-2275
-
(2003)
J Clin Oncol
, vol.21
, pp. 2268-2275
-
-
Kemeny, M.M.1
Peterson, B.L.2
Kornblith, A.B.3
Muss, H.B.4
Wheeler, J.5
Levine, E.6
-
3
-
-
4644265882
-
Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node negative breast cancer
-
Hebert-Croteau N., Brisson J., Latreille J., Rivard M., Abdelaziz N., and Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node negative breast cancer. J Clin Oncol 22 (2004) 3685-3693
-
(2004)
J Clin Oncol
, vol.22
, pp. 3685-3693
-
-
Hebert-Croteau, N.1
Brisson, J.2
Latreille, J.3
Rivard, M.4
Abdelaziz, N.5
Martin, G.6
-
4
-
-
33645362243
-
Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden
-
Eaker S., Dickman P.W., Bergkvist L., and Holmberg L. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 3 (2006) e25
-
(2006)
PLoS Med
, vol.3
-
-
Eaker, S.1
Dickman, P.W.2
Bergkvist, L.3
Holmberg, L.4
-
5
-
-
0034894204
-
Cancer mortality in the elderly, 1960-1998: a worldwide approach
-
La Vecchia C., Lucchini F., Negri E., and Levi F. Cancer mortality in the elderly, 1960-1998: a worldwide approach. Oncol Spectrums 2 (2001) 386-394
-
(2001)
Oncol Spectrums
, vol.2
, pp. 386-394
-
-
La Vecchia, C.1
Lucchini, F.2
Negri, E.3
Levi, F.4
-
6
-
-
27244434470
-
Effect of screening and adjuvant therapy on mortality from breast cancer
-
Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 (2005) 1784-1792
-
(2005)
N Engl J Med
, vol.353
, pp. 1784-1792
-
-
Berry, D.A.1
Cronin, K.A.2
Plevritis, S.K.3
Fryback, D.G.4
Clarke, L.5
Zelen, M.6
-
7
-
-
35649008185
-
-
National center for health and statistics. Tables on trends in health and aging; life expectancy. 〈www.cdc.gov〉, 2007 [report].
-
-
-
-
8
-
-
0034607235
-
Tumor characteristics and clinical outcome of elderly women with breast cancer
-
Diab S.G., Elledge R.M., and Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92 (2000) 550-556
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 550-556
-
-
Diab, S.G.1
Elledge, R.M.2
Clark, G.M.3
-
9
-
-
0037334579
-
Primary breast cancer in elderly women: biological profile and relation with clinical outcome
-
Daidone M.G., Coradini D., Martelli G., and Veneroni S. Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol Hematol 45 (2003) 313-325
-
(2003)
Crit Rev Oncol Hematol
, vol.45
, pp. 313-325
-
-
Daidone, M.G.1
Coradini, D.2
Martelli, G.3
Veneroni, S.4
-
10
-
-
27644459506
-
Modeling the effect of age in T1-2 breast cancer using the SEER database
-
Tai P., Cserni G., Van De S.J., Vlastos G., Voordeckers M., Royce M., et al. Modeling the effect of age in T1-2 breast cancer using the SEER database. BMC Cancer 5 (2005) 130
-
(2005)
BMC Cancer
, vol.5
, pp. 130
-
-
Tai, P.1
Cserni, G.2
Van De, S.J.3
Vlastos, G.4
Voordeckers, M.5
Royce, M.6
-
11
-
-
0034063101
-
Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
-
Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
-
(2000)
J Clin Oncol
, vol.18
, pp. 1220-1229
-
-
Whelan, T.J.1
Julian, J.2
Wright, J.3
Jadad, A.R.4
Levine, M.L.5
-
12
-
-
33750615608
-
Postmastectomy radiation and survival in older women with breast cancer
-
Smith B.D., Haffty B.G., Hurria A., Galusha D.H., and Gross C.P. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24 (2006) 4901-4907
-
(2006)
J Clin Oncol
, vol.24
, pp. 4901-4907
-
-
Smith, B.D.1
Haffty, B.G.2
Hurria, A.3
Galusha, D.H.4
Gross, C.P.5
-
13
-
-
1042280379
-
Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality
-
Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 115-121
-
-
Vinh-Hung, V.1
Verschraegen, C.2
-
14
-
-
0034690745
-
-
Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
-
-
-
-
15
-
-
29144475553
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
-
Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
-
(2005)
Lancet
, vol.366
, pp. 2087-2106
-
-
Clarke, M.1
Collins, R.2
Darby, S.3
Davies, C.4
Elphinstone, P.5
Evans, E.6
-
16
-
-
4344628403
-
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
-
Hughes K.S., Schnaper L.A., Berry D., Cirrincione C., McCormick B., Shank B., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
-
(2004)
N Engl J Med
, vol.351
, pp. 971-977
-
-
Hughes, K.S.1
Schnaper, L.A.2
Berry, D.3
Cirrincione, C.4
McCormick, B.5
Shank, B.6
-
17
-
-
19344364880
-
-
Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
-
-
-
-
18
-
-
11444251764
-
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
-
Howell A., Cuzick J., Baum M., Buzdar A., Dowsett M., Forbes J.F., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
-
(2005)
Lancet
, vol.365
, pp. 60-62
-
-
Howell, A.1
Cuzick, J.2
Baum, M.3
Buzdar, A.4
Dowsett, M.5
Forbes, J.F.6
-
19
-
-
33947510501
-
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
-
Coates A.S., Keshaviah A., Thurlimann B., Mouridsen H., Mauriac L., Forbes J.F., et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25 (2007) 486-492
-
(2007)
J Clin Oncol
, vol.25
, pp. 486-492
-
-
Coates, A.S.1
Keshaviah, A.2
Thurlimann, B.3
Mouridsen, H.4
Mauriac, L.5
Forbes, J.F.6
-
20
-
-
10744223655
-
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
-
Coombes R.C., Hall E., Gibson L.J., Paridaens R., Jassem J., Delozier T., et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350 (2004) 1081-1092
-
(2004)
N Engl J Med
, vol.350
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
Paridaens, R.4
Jassem, J.5
Delozier, T.6
-
21
-
-
23444446523
-
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
-
Jakesz R., Jonat W., Gnant M., Mittlboeck M., Greil R., Tausch C., et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366 (2005) 455-462
-
(2005)
Lancet
, vol.366
, pp. 455-462
-
-
Jakesz, R.1
Jonat, W.2
Gnant, M.3
Mittlboeck, M.4
Greil, R.5
Tausch, C.6
-
23
-
-
24744450378
-
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17
-
Goss P.E., Ingle J.N., Martino S., Robert N.J., Muss H.B., Piccart M.J., et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97 (2005) 1262-1271
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1262-1271
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
Robert, N.J.4
Muss, H.B.5
Piccart, M.J.6
-
24
-
-
20044382779
-
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
-
Winer E.P., Hudis C., Burstein H.J., Wolff A.C., Pritchard K.I., Ingle J.N., et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23 (2005) 619-629
-
(2005)
J Clin Oncol
, vol.23
, pp. 619-629
-
-
Winer, E.P.1
Hudis, C.2
Burstein, H.J.3
Wolff, A.C.4
Pritchard, K.I.5
Ingle, J.N.6
-
25
-
-
33745528525
-
Use and outcomes of adjuvant chemotherapy in older women with breast cancer
-
Giordano S.H., Duan Z., Kuo Y.F., Hortobagyi G.N., and Goodwin J.S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24 (2006) 2750-2756
-
(2006)
J Clin Oncol
, vol.24
, pp. 2750-2756
-
-
Giordano, S.H.1
Duan, Z.2
Kuo, Y.F.3
Hortobagyi, G.N.4
Goodwin, J.S.5
-
26
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer
-
Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., et al. A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer. N Engl J Med 351 (2004) 2817-2826
-
(2004)
N Engl J Med
, vol.351
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
-
27
-
-
33744814477
-
Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer
-
Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., et al. Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer. J Clin Oncol 24 (2006) 3726-3734
-
(2006)
J Clin Oncol
, vol.24
, pp. 3726-3734
-
-
Paik, S.1
Tang, G.2
Shak, S.3
Kim, C.4
Baker, J.5
Kim, W.6
-
28
-
-
20044388527
-
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
-
Muss H.B., Woolf S., Berry D., Cirrincione C., Weiss R.B., Budman D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293 (2005) 1073-1081
-
(2005)
JAMA
, vol.293
, pp. 1073-1081
-
-
Muss, H.B.1
Woolf, S.2
Berry, D.3
Cirrincione, C.4
Weiss, R.B.5
Budman, D.6
-
29
-
-
16544369385
-
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial
-
Fargeot P., Bonneterre J., Roche H., Lortholary A., Campone M., Van P.I., et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial. J Clin Oncol 22 (2004) 4622-4630
-
(2004)
J Clin Oncol
, vol.22
, pp. 4622-4630
-
-
Fargeot, P.1
Bonneterre, J.2
Roche, H.3
Lortholary, A.4
Campone, M.5
Van, P.I.6
-
30
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
-
Romond E.H., Perez E.A., Bryant J., Suman V.J., Geyer Jr. C.E., Davidson N.E., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 (2005) 1673-1684
-
(2005)
N Engl J Med
, vol.353
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
Suman, V.J.4
Geyer Jr., C.E.5
Davidson, N.E.6
-
31
-
-
26844503270
-
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
-
Piccart-Gebhart M.J., Procter M., Leyland-Jones B., Goldhirsch A., Untch M., Smith I., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 (2005) 1659-1672
-
(2005)
N Engl J Med
, vol.353
, pp. 1659-1672
-
-
Piccart-Gebhart, M.J.1
Procter, M.2
Leyland-Jones, B.3
Goldhirsch, A.4
Untch, M.5
Smith, I.6
-
32
-
-
35648961161
-
-
Slamon D, Eiermann W, Robert N, et al. 2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab with docetaxel, carboplatin and trastuzumab in Her2neu postiive early breast cancer patients. San Antonio Breast Cancer Symposium 2006 (Abstract 52) see www.sabcs.org.
-
-
-
-
33
-
-
17044460539
-
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
-
Crivellari D., Bonetti M., Castiglione-Gertsch M., Gelber R.D., Rudenstam C.M., Thurlimann B., et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18 (2000) 1412-1422
-
(2000)
J Clin Oncol
, vol.18
, pp. 1412-1422
-
-
Crivellari, D.1
Bonetti, M.2
Castiglione-Gertsch, M.3
Gelber, R.D.4
Rudenstam, C.M.5
Thurlimann, B.6
-
34
-
-
85074742863
-
Toxicity of older and younger patients treated with intensive adjuvant chemotherapy for node-positive breast cancer: the CALGB experience
-
[abstract]
-
Muss H., Berry D., Cirrincione C., et al. Toxicity of older and younger patients treated with intensive adjuvant chemotherapy for node-positive breast cancer: the CALGB experience. Proc Annu Meet Am Soc Clin Oncol 24 (2006) 17s [abstract]
-
(2006)
Proc Annu Meet Am Soc Clin Oncol
, vol.24
-
-
Muss, H.1
Berry, D.2
Cirrincione, C.3
-
35
-
-
0037319948
-
Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting
-
Repetto L., Carreca I., Maraninchi D., Aapro M., Calabresi P., and Balducci L. Use of growth factors in the elderly patient with cancer: a report from the Second International Society for Geriatric Oncology (SIOG) 2001 meeting. Crit Rev Oncol Hematol 45 (2003) 123-128
-
(2003)
Crit Rev Oncol Hematol
, vol.45
, pp. 123-128
-
-
Repetto, L.1
Carreca, I.2
Maraninchi, D.3
Aapro, M.4
Calabresi, P.5
Balducci, L.6
-
36
-
-
33749609130
-
Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C)
-
[abstract]
-
Giordano S.H., Pinder M., Duan Z., Hortobagyi G., and Goodwin J. Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C). Proc Am Soc Clin Oncol 24 (2006) 8s [abstract]
-
(2006)
Proc Am Soc Clin Oncol
, vol.24
-
-
Giordano, S.H.1
Pinder, M.2
Duan, Z.3
Hortobagyi, G.4
Goodwin, J.5
-
37
-
-
1542753592
-
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices
-
Lyman G.H., Dale D.C., and Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 21 (2003) 4524-4531
-
(2003)
J Clin Oncol
, vol.21
, pp. 4524-4531
-
-
Lyman, G.H.1
Dale, D.C.2
Crawford, J.3
-
38
-
-
0019378585
-
Dose-response effect of adjuvant chemotherapy in breast cancer
-
Bonadonna G., and Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304 (1981) 10-15
-
(1981)
N Engl J Med
, vol.304
, pp. 10-15
-
-
Bonadonna, G.1
Valagussa, P.2
-
39
-
-
0032547342
-
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
-
Budman D.R., Berry D.A., Cirrincione C.T., Henderson I.C., Wood W.C., Weiss R.B., et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 90 (1998) 1205-1211
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1205-1211
-
-
Budman, D.R.1
Berry, D.A.2
Cirrincione, C.T.3
Henderson, I.C.4
Wood, W.C.5
Weiss, R.B.6
-
40
-
-
0035253733
-
Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial
-
French Adjuvant Study Group
-
French Adjuvant Study Group. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial. J Clin Oncol 19 (2001) 602-611
-
(2001)
J Clin Oncol
, vol.19
, pp. 602-611
-
-
-
41
-
-
85074743625
-
Acute myeloid leukemia (AML) in older women after adjuvant breast cancer therapy
-
[abstract]
-
Patt D., Duan Z., Hortobagyi G., and Giordano S.H. Acute myeloid leukemia (AML) in older women after adjuvant breast cancer therapy. Proc Am Soc Clin Oncol 24 (2006) 17s [abstract]
-
(2006)
Proc Am Soc Clin Oncol
, vol.24
-
-
Patt, D.1
Duan, Z.2
Hortobagyi, G.3
Giordano, S.H.4
-
42
-
-
33749452243
-
Increased risk of acute myeloid leukaemia after treatment for breast cancer
-
Renella R., Verkooijen H.M., Fioretta G., Vlastos G., Kurtz J., Sappino A.P., et al. Increased risk of acute myeloid leukaemia after treatment for breast cancer. Breast 15 (2005) 614-619
-
(2005)
Breast
, vol.15
, pp. 614-619
-
-
Renella, R.1
Verkooijen, H.M.2
Fioretta, G.3
Vlastos, G.4
Kurtz, J.5
Sappino, A.P.6
-
43
-
-
0028156819
-
The effect of co-morbidity on 3-year survival of women with primary breast cancer
-
Satariano W.A., and Ragland D.R. The effect of co-morbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120 (1994) 104-110
-
(1994)
Ann Intern Med
, vol.120
, pp. 104-110
-
-
Satariano, W.A.1
Ragland, D.R.2
-
44
-
-
0035925169
-
Effect of age and co-morbidity in postmenopausal breast cancer patients aged 55 years and older
-
Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., and Yates J.W. Effect of age and co-morbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285 (2001) 885-892
-
(2001)
JAMA
, vol.285
, pp. 885-892
-
-
Yancik, R.1
Wesley, M.N.2
Ries, L.A.3
Havlik, R.J.4
Edwards, B.K.5
Yates, J.W.6
-
45
-
-
4444315066
-
Probabilities of death from breast cancer and other causes among female breast cancer patients
-
Schairer C., Mink P.J., Carroll L., and Devesa S.S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96 (2004) 1311-1321
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1311-1321
-
-
Schairer, C.1
Mink, P.J.2
Carroll, L.3
Devesa, S.S.4
-
46
-
-
0031901577
-
Co-morbidity and functional status are independent in older cancer patients
-
Extermann M., Overcash J., Lyman G.H., Parr J., and Balducci L. Co-morbidity and functional status are independent in older cancer patients. J Clin Oncol 16 (1998) 1582-1587
-
(1998)
J Clin Oncol
, vol.16
, pp. 1582-1587
-
-
Extermann, M.1
Overcash, J.2
Lyman, G.H.3
Parr, J.4
Balducci, L.5
-
47
-
-
33745611120
-
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
-
Hurria A., Hurria A., Zuckerman E., Panageas K.S., Fornier M., D'Andrea G., et al. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc 54 (2006) 1119-1124
-
(2006)
J Am Geriatr Soc
, vol.54
, pp. 1119-1124
-
-
Hurria, A.1
Hurria, A.2
Zuckerman, E.3
Panageas, K.S.4
Fornier, M.5
D'Andrea, G.6
-
48
-
-
0029865134
-
Estimating treatment benefits for the elderly: the effect of competing risks
-
Welch H.G., Albertsen P.C., Nease R.F., Bubolz T.A., and Wasson J.H. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 124 (1996) 577-584
-
(1996)
Ann Intern Med
, vol.124
, pp. 577-584
-
-
Welch, H.G.1
Albertsen, P.C.2
Nease, R.F.3
Bubolz, T.A.4
Wasson, J.H.5
-
49
-
-
27244441470
-
Developing a cancer-specific geriatric assessment: a feasibility study
-
Hurria A., Gupta S., Zauderer M., Zuckerman E.L., Cohen H.J., Muss H., et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104 (2005) 1998-2005
-
(2005)
Cancer
, vol.104
, pp. 1998-2005
-
-
Hurria, A.1
Gupta, S.2
Zauderer, M.3
Zuckerman, E.L.4
Cohen, H.J.5
Muss, H.6
-
50
-
-
33747797001
-
Geriatric assessment for oncologists: rationale and future directions
-
Hurria A., Lachs M.S., Cohen H.J., Muss H.B., and Kornblith A.B. Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol 59 (2006) 211-217
-
(2006)
Crit Rev Oncol Hematol
, vol.59
, pp. 211-217
-
-
Hurria, A.1
Lachs, M.S.2
Cohen, H.J.3
Muss, H.B.4
Kornblith, A.B.5
-
51
-
-
24044454968
-
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
-
Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55 (2005) 241-252
-
(2005)
Crit Rev Oncol Hematol
, vol.55
, pp. 241-252
-
-
Extermann, M.1
Aapro, M.2
Bernabei, R.3
Cohen, H.J.4
Droz, J.P.5
Lichtman, S.6
-
52
-
-
0345743476
-
A comprehensive geriatric intervention detects multiple problems in older breast cancer patients
-
Extermann M., Meyer J., McGinnis M., Crocker T.T., Corcoran M.B., Yoder J., et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 49 (2004) 69-75
-
(2004)
Crit Rev Oncol Hematol
, vol.49
, pp. 69-75
-
-
Extermann, M.1
Meyer, J.2
McGinnis, M.3
Crocker, T.T.4
Corcoran, M.B.5
Yoder, J.6
-
53
-
-
33746866643
-
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
-
Hurria A., Goldfarb S., Rosen C., Holland J., Zuckerman E., Lachs M.S., et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 98 (2006) 343-348
-
(2006)
Breast Cancer Res Treat
, vol.98
, pp. 343-348
-
-
Hurria, A.1
Goldfarb, S.2
Rosen, C.3
Holland, J.4
Zuckerman, E.5
Lachs, M.S.6
-
54
-
-
0037811742
-
Barriers to clinical trial participation by older women with breast cancer
-
Kemeny M.M., Peterson B.L., Kornblith A.B., Muss H.B., Wheeler J., Levine E., et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21 (2003) 2268-2275
-
(2003)
J Clin Oncol
, vol.21
, pp. 2268-2275
-
-
Kemeny, M.M.1
Peterson, B.L.2
Kornblith, A.B.3
Muss, H.B.4
Wheeler, J.5
Levine, E.6
-
55
-
-
0037089630
-
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials
-
Sateren W.B., Trimble E.L., Abrams J., Brawley O., Breen N., Ford L., et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20 (2002) 2109-2117
-
(2002)
J Clin Oncol
, vol.20
, pp. 2109-2117
-
-
Sateren, W.B.1
Trimble, E.L.2
Abrams, J.3
Brawley, O.4
Breen, N.5
Ford, L.6
-
56
-
-
0142008446
-
Undertreatment strongly decreases prognosis of breast cancer in elderly women
-
Bouchardy C., Rapiti E., Fioretta G., Laissue P., Neyroud-Caspar I., Schafer P., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21 (2003) 3580-3587
-
(2003)
J Clin Oncol
, vol.21
, pp. 3580-3587
-
-
Bouchardy, C.1
Rapiti, E.2
Fioretta, G.3
Laissue, P.4
Neyroud-Caspar, I.5
Schafer, P.6
-
58
-
-
0037687355
-
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
-
Citron M.L., Berry D.A., Cirrincione C., Hudis C., Winer E.P., Gradishar W.J., et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21 (2003) 1431-1439
-
(2003)
J Clin Oncol
, vol.21
, pp. 1431-1439
-
-
Citron, M.L.1
Berry, D.A.2
Cirrincione, C.3
Hudis, C.4
Winer, E.P.5
Gradishar, W.J.6
-
59
-
-
21144435932
-
Adjuvant docetaxel for node-positive breast cancer
-
Martin M., Pienkowski T., Mackey J., Pawlicki M., Guastalla J.P., Weaver C., et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352 (2005) 2302-2313
-
(2005)
N Engl J Med
, vol.352
, pp. 2302-2313
-
-
Martin, M.1
Pienkowski, T.2
Mackey, J.3
Pawlicki, M.4
Guastalla, J.P.5
Weaver, C.6
|